Navigation Links
Fungal pill could provide asthma relief for 150,000 UK sufferers
Date:12/29/2008

Up to 150,000 people suffering from severe asthma in the UK could benefit from taking antifungal medication already available from pharmacists, new research has found.

University of Manchester scientists found that pills used to treat everyday fungal infections greatly improved symptoms of asthma in those patients that had an allergic reaction to one or more fungi.

The study, carried out at four hospitals in northwest England and published in the American Journal of Respiratory and Critical Care Medicine, is the first to show that antifungal therapy can improve the symptoms of those who suffer from severe asthma.

The researchers compared the oral antifungal drug itraconazole with a placebo over eight months and found that nearly 60% of patients taking the drug showed significant improvement in their symptoms.

"Only patients with a positive skin or blood test for fungal allergy were included in the study," said Professor David Denning, who is based at the University Hospital of South Manchester.

"Severe asthma affects between five and 10% of adult asthmatics and probably 25 to 50% of these patients showed allergy to one or more fungi. Since about 60% of those treated benefited from the treatment, we believe that antifungal therapy may be helpful in as many as 150,000 adults with asthma in the UK."

The clinical study of 58 patients at the University Hospital of South Manchester, Salford Royal, Royal Preston and North Manchester General hospitals showed statistically significant improvements in a validated quality of life score. Patients' asthma and nasal symptoms deteriorated within four months of stopping therapy.

Dr Robert Niven, from The University of Manchester and the University Hospital of South Manchester, said: "This pioneering study indicates that fungal allergy is important in some patients with severe asthma, and that oral antifungal therapy is worth trying in some difficult-to-treat patients. Clearly itraconazole will not suit everyone, and is not always helpful, but, when it is, the effect is dramatic."

Dr Ronan O'Driscoll, at Salford Royal Hospital, added: "It's good news for patients with severe asthma to have an existing anti-fungal drug recognised as having benefits for asthma patients with fungal allergy. We found that many patients were only picked up by extensive skin and blood test screening for fungal allergy, so a change of clinical practice will be required to identify all the patients who might respond to itraconazole."


'/>"/>

Contact: Aeron Haworth
aeron.haworth@manchester.ac.uk
44-771-788-3563
University of Manchester
Source:Eurekalert

Related medicine news :

1. New IDSA Clinical Practice Guidelines Recommend NOXAFIL(R) (Posaconazole) for Antifungal Prophylaxis in Certain High-Risk Patients
2. VBI, Mayo Clinic investigate link between fungal proteins, innate immunity and asthma
3. Mylans Matrix First-to-File on Generic Version of Vfend(R) Antifungal
4. Echinocandins Show Growth Among All Antifungal Classes
5. Uptake of Next-Generation Antifungals Has Intensified Competition in the Severe Fungal Infections Drug Market
6. Voriconazole: A highly potent treatment for fungal infections
7. Anti-fungal drug offers great benefits to some with severe asthma
8. Study provides hope that some transplant patients could live free of antirejection drugs
9. Study provides hope that some transplant patients could live free of anti-rejection drugs
10. HIV denialists spread misinformation online -- consequences could be deadly; and more
11. Virus Could Help Drive Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... May 02, 2016 , ... MedPro Waste Disposal, LLC (MedPro) is proud ... now offers its mail back service for an all-inclusive rate. MedPro Disposal President, Dan ... provide service to all of the clients in the country who are looking for ...
(Date:5/2/2016)... Vegas, NV (PRWEB) , ... May 02, 2016 ... ... Specialty Pharmacy Times, has announced a new Specialty Pharmacy Patient Satisfaction Award that ... determined based on the quarterly results from Zitter Health Insights’ Specialty Pharmacy Patient ...
(Date:5/2/2016)... ... , ... The 2016 World Ultimate & Guts Championship (WUGC) Mixed roster was announced in February ... The WUGC is being held in London, England this year from June 18-25. At the ... another gold in the women’s masters division, and a silver in the women’s division, so ...
(Date:5/2/2016)... ... May 02, 2016 , ... Pregnancy Awareness Month offers a great time to ... , “If you are ready to have a baby, it’s best to get started ... Babies is your Personal Conception & Pregnancy Organizer, written for women who plan on ...
(Date:5/2/2016)... ... May 02, 2016 , ... A research ... two groundbreaking studies that determined that the adjustability and adaptability of pediatric support ... prevention of pressure injuries, which are now referred to as “pressure injuries” by ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... April 29, 2016 Acquisition ... Sciences, Product Development Capabilities in North ... Base . Indegene ( http://www.indegene.com ... the acquisition of Skura Corporation,s life science business. ... adaptive sales enablement technology for life science organizations ...
(Date:4/28/2016)... 2016  While Abbott,s announced purchase of St. ... repair and stent business, healthcare research firm Kalorama ... firmly into patient monitoring.  Kalorama said that patient ... areas, with double-digit growth expected the next 5 ... Remote Patient Monitoring . Abbott Laboratories agreed ...
(Date:4/28/2016)... , April 28, 2016 ... insights on healthcare, announced today that it has been ... Cool Vendor in Life Sciences, 2016, ... 2016.  The report focuses on life-science- oriented analytics, algorithms ... from patients and doctors, confirm medication ingestion, and analyze ...
Breaking Medicine Technology: